Background: Androgenic alopecia (AGA) is a prevalent hair condition characterised by progressive pattern hair loss in the frontotemporal and vertex areas of the scalp in both men and women. Androgenic alopecia worsens with age and lowers patients' body image satisfaction. Androgenic alopecia affects at least fifty percent of men by the age of fifty, and up to seventy percent of all men in their later years. Aim of the Work: To assess the effectiveness and safety of therapies for androgenetic alopecia in males. Patients and Methods: his randomized interventional study included 40 male patients complaining of AGA. They were selected from those attending the Outpatient Clinic of the Dermatology & Andrology Department, Benha University Hospital science 2019 to 2023. This research comprised 40 male patients with AGA complaints. They were picked from Benha University Hospital's Dermatology and Andrology Department Outpatient Clinic patients. Results: It was discovered that medications for the management of male androgenetic alopecia are both safe and effective. Conclusion: For the treatment of male androgenetic alopecia, it was discovered that therapies are both safe and effective.